NEUROCHEMICAL AND FUNCTIONAL CONSEQUENCES FOLLOWING 1-METHYL-4-PHENYL-1,2,5,6-TETRAHYDROPYRIDINE (MPTP) AND METHAMPHETAMINE

被引:58
作者
JARVIS, MF
WAGNER, GC
机构
关键词
D O I
10.1016/0024-3205(85)90067-0
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:249 / 254
页数:6
相关论文
共 10 条
[1]   DEPLETION OF BRAIN NORADRENALINE AND DOPAMINE BY 6-HYDROXYDOPAMINE [J].
BREESE, GR ;
TRAYLOR, TD .
BRITISH JOURNAL OF PHARMACOLOGY, 1971, 42 (01) :88-&
[2]   A PRIMATE MODEL OF PARKINSONISM - SELECTIVE DESTRUCTION OF DOPAMINERGIC-NEURONS IN THE PARS COMPACTA OF THE SUBSTANTIA NIGRA BY N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE [J].
BURNS, RS ;
CHIUEH, CC ;
MARKEY, SP ;
EBERT, MH ;
JACOBOWITZ, DM ;
KOPIN, IJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14) :4546-4550
[3]   METABOLISM OF THE NEUROTOXIC TERTIARY AMINE, MPTP, BY BRAIN MONOAMINE-OXIDASE [J].
CHIBA, K ;
TREVOR, A ;
CASTAGNOLI, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (02) :574-578
[4]   CHRONIC PARKINSONISM SECONDARY TO INTRAVENOUS-INJECTION OF MEPERIDINE ANALOGS [J].
DAVIS, GC ;
WILLIAMS, AC ;
MARKEY, SP ;
EBERT, MH ;
CAINE, ED ;
REICHERT, CM ;
KOPIN, IJ .
PSYCHIATRY RESEARCH, 1979, 1 (03) :249-254
[5]   CHARACTERIZATION OF NORMAL AND SUPER-SENSITIVE DOPAMINE-RECEPTORS - EFFECTS OF ERGOT DRUGS AND NEUROPEPTIDES [J].
FUXE, K ;
AGNATI, LF ;
KOHLER, C ;
KUONEN, D ;
OGREN, SO ;
ANDERSSON, K ;
HOKFELT, T .
JOURNAL OF NEURAL TRANSMISSION, 1981, 51 (1-2) :3-37
[6]  
HEIKKILA RE, 1984, NATURE, V311, P467, DOI 10.1038/311467a0
[7]   CHRONIC PARKINSONISM IN HUMANS DUE TO A PRODUCT OF MEPERIDINE-ANALOG SYNTHESIS [J].
LANGSTON, JW ;
BALLARD, P ;
TETRUD, JW ;
IRWIN, I .
SCIENCE, 1983, 219 (4587) :979-980
[8]  
LANGSTON JW, 1984, SCIENCE, V225, P1382
[9]   INTRANEURONAL GENERATION OF A PYRIDINIUM METABOLITE MAY CAUSE DRUG-INDUCED PARKINSONISM [J].
MARKEY, SP ;
JOHANNESSEN, JN ;
CHIUEH, CC ;
BURNS, RS ;
HERKENHAM, MA .
NATURE, 1984, 311 (5985) :464-467
[10]   LONG-LASTING DEPLETIONS OF STRIATAL DOPAMINE AND LOSS OF DOPAMINE UPTAKE SITES FOLLOWING REPEATED ADMINISTRATION OF METHAMPHETAMINE [J].
WAGNER, GC ;
RICAURTE, GA ;
SEIDEN, LS ;
SCHUSTER, CR ;
MILLER, RJ ;
WESTLEY, J .
BRAIN RESEARCH, 1980, 181 (01) :151-160